Two new medications will be available in the UAE this month. One of them is said to be a breakthrough drug involving diabetes therapy, whilst the other could decrease mortality in heart failure patients by 20%. Both drugs have been approved by the US Food and Drug Administration (FDA), and will be registered in the Emirates before the end of October. The UAE is the first country to introduce the said medicines in the MENA region. The news was announced by His Excellency Dr. Amin Al Amiri, Assistant Undersecretary for Public Health and Licensing at the UAE Ministry of Health at an ongoing pharmaceutical event in Dubai.
UAE, Russian Presidents discuss ties, regional developments
UAE begins loading humanitarian vessel bound for Gaza
Italian president praises Zayed Award honour for Armenia, Azerbaijan
Dubai opens major Al Qudra bridge to cut travel time by over 50%
Cyber Security Council: Stolen logins drive majority of financial attacks
